Methods of preventing and removing trisulfide bonds
View Patent ↗The present invention pertains to methods of preventing and eliminating trisulfide bonds in proteins such as antibodies. In one embodiment, trisulfide bonds in proteins are converted to disulfide bonds as part of chromatographic purification procedures. In another embodiment, the formation of trisulfide bonds in proteins is inhibited by implementation of methods described herein during the cell culture production of such proteins. In another embodiment, monoclonal antibodies are produced by the methods described herein.
1. A method for convert in trisulfide bonds to disulfide bonds in antibodies or antigen-binding fragments thereof wherein the method comprises:
(a) allowing antibodies or antigen-binding fragments thereof in a solution comprising at least one antibody or antigen-binding fragment thereof with at least one trisulfide bond linking a heavy chain constant region and a light chain constant region of the at least one antibody or antigen-binding fragment thereof to contact and associate with a solid support;
(b) exposing the at least one antibody or antigen-binding fragment thereof to a reducing agent at an effective concentration to convert the trisulfide bond to a disulfide bond; and
(c) removing the reducing agent from the at least one antibody or antigen-binding fragment thereof,
wherein steps (a) and (b) are performed simultaneously or in any sequential order such that the reducing agent is applied to the solid support, wherein steps (a) and (b) are followed subsequently by step (c),
wherein the reducing agent is selected from cysteine L-cysteine, cysteamine reduced glutathione (GSH) and L-GSH, and
wherein the method reduces heat induced fragmentation in the antibodies or antigen-binding fragments thereof compared to antibodies or antigen-binding fragments not exposed to the reducing agent, wherein heat induced fragmentation is measured by denaturing, non-reducing capillary electrophoresis.
2. The method of claim 1 , wherein the solution lacking the reducing agent comprises an alkali metal salt.
3. The method of claim 1 , wherein the solid support specifically binds antibodies.
4. The method of claim 1 , wherein the concentration of the reducing agent is selected from:
(a) about 0.5 to about 8 mM;
(b) about 0.5 to about 5 mM;
(c) about 0.5 to about 3 mM;
(d) about 0.5 to about 1 mM;
(e) about 8 mM;
(f) about 5 mM;
(g) about 3 mM;
(h) about 1 mM; and,
(i) about 0.5 mM.
5. The, method of claim 1 , wherein step (c) is followed by: (d) preparing said antibodies or antigen-binding fragments thereof in a composition for long-term storage.
6. The method of claim 5 , wherein said method reduces cleavage or loss of covalent bonding of antibody light chains from intact antibody molecules or reduces the formation of antibody aggregates.
7. The method of claim 5 , wherein said antibodies or antigen-binding fragments are stored in a substantially hydrated form.
8. The method of claim 5 , wherein said long term storage comprises storage for a period of 1 month or longer at a temperature selected from:
(a) −70° C. or below;
(b) about −70° C.;
(c) −70° C. or above;
(d) −20° C. or below;
(e) −20° C.;
(f) −20° C. or above;
(g) 0° C. or below;
(h) about 0° C.;
(i) 0° C. or above;
(j) 4° C. or below;
(k) about 4° C.;
(l) 4° C. or above; and
(m) 20° C. or below.
9. The method of claim 5 , wherein said antibodies or antigen-binding fragments thereof are stored in a substantially non-hydrated form.
10. The method of claim 1 , wherein the solid support is a chromatographic medium.
11. The method of claim 10 , wherein the chromatographic medium is a Protein A chromatographic medium.
12. The method of claim 1 , wherein the reducing agent is cysteine and the solid support is a Protein A chromatographic medium.
13. The method of claim 4 , wherein the concentration of the reducing agent is about 0.5 to about 5 mM.
14. A method for converting trisulfide bonds to disulfide bonds in antibodies or antigen-binding fragments thereof wherein the method comprises:
(a) allowing antibodies or antigen-binding fragments thereof in a solution comprising at least one antibody or antigen-binding fragment thereof with at least one trisulfide bond linking a heavy chain constant region and a light chain constant region of the at least one antibody or antigen-binding fragment thereof to contact and associate with a Protein A chromatographic medium;
(b) exposing the at least one antibody or antigen-binding fragment thereof and the Protein A chromatographic medium to cysteine at an effective concentration to convert the trisulfide bond to a disulfide bond; and
(c) eluting the antibodies or antigen-binding fragments thereof from the Protein A chromatographic medium,
wherein the reducing agent is selected from cysteine, L-cysteine, cysteamine, reduced glutathione (GSH) and L-GSH, and
wherein the method reduces heat induced fragmentation of the antibodies or antigen-binding fragments thereof compared to antibodies or antigen-binding fragments not exposed to cysteine, wherein heat induced fragmentation is measured by denaturing, non-reducing capillary electrophoresis.
15. The method of claim 14 , wherein the concentration of cysteine is about 3 mM.
16. A method for reducing heat induced fragmentation in antibodies or antigen-binding fragments thereof wherein the method comprises:
(a) allowing antibodies or antigen-binding fragments thereof in a solution comprising at least one antibody or antigen-binding fragment thereof with at least one trisulfide bond linking a heavy chain constant region and a light chain constant region of the at least one antibody or antigen-binding fragment thereof to contact and associate with a Protein A chromatographic medium;
(b) exposing the at least one antibody or antigen-binding fragment thereof and the Protein A chromatographic medium to glutathione at an effective concentration to convert the trisulfide bond to a disulfide bond; and
(c) eluting the antibodies or antigen-binding fragments thereof from the Protein A chromatographic medium,
wherein the reducing agent is selected from cysteine, L-cysteine, cysteamine, reduced glutathione (GSH) and L-GSH, and
wherein said method reduces heat induced fragmentation of the antibodies or antigen-binding fragments thereof compared to antibodies or antigen-binding fragments not exposed to glutathione, wherein heat induced fragmentation is measured by denaturing, non-reducing capillary electrophoresis.
17. The method of claim 16 , wherein the concentration of glutathione is about 1 mM.
18. The method of claim 1 , wherein the antibodies or antigen-binding, fragments thereof are exposed to a reducing agent at a pH of from about 6 to about 8.
19. The method of claim 1 , wherein the antibodies or antigen-binding fragments thereof are IgG1, IgG2, IgG3 or IgG4.
20. The method of claim 1 , wherein the antibodies or antigen-binding fragments thereof are IgG1.